S&P Equity Research downgrades Taubman Centers (NYSE: TCO) from Buy to Hold, on valuation. Price target increased from $46 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE